Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency

Transfusion and Apheresis Science

Volumn 32, Issue 3, 2005, Pages 247-253

  Kreuz, Wolfhart ^a   Meili, Esther ^b   Peter Salonen, Kristiina ^c   Haertel, Sabine ^d   Devay, Jan ^e   Krzensk, Udo ^d   Egbring, Rudolf ^f  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^e Aventis Pharma   (Switzerland)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Afibrinogenaemia; Bleedings; Coagulation; Fibrinogen substitution; Fibrinogen deficiency disorders

Indexed keywords

FIBRINOGEN; HAEMOCOMPLETTAN P;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AFIBRINOGENEMIA; ANAPHYLAXIS; ARTICLE; BACKACHE; BLEEDING; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CYANOSIS; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; DRUG TOLERABILITY; DYSFIBRINOGENEMIA; FEMALE; FEMUR FRACTURE; FEMUR NECK; FIBRINOGEN DEFECT; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; HYPOFIBRINOGENEMIA; INFANT; LABORATORY TEST; LUNG EMBOLISM; MALE; MULTICENTER STUDY; NEWBORN; OSTEOSYNTHESIS; PATIENT; PREOPERATIVE CARE; PROPHYLAXIS; RECORDING; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

AFIBRINOGENEMIA; BLOOD COMPONENT TRANSFUSION; FEMALE; FIBRINOGEN; HUMANS; MALE; PRESERVATION, BIOLOGICAL; RETROSPECTIVE STUDIES;

EID: 20444408784     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2004.08.003     Document Type: Article

References (29)

1. E.A. Caspary, and R.A. Kekwick Some physicochemical properties of human fibrinogen Biochem J 67 1957 41 48
2. J. Hermans, and J. McDonagh Fibrin: Structure and interactions Semin Thromb Hemost 8 1982 11 24
3. A. Henschen Disulphide bridges in the middle part of human fibrinogen Hoppe-Seyler's Z Physiol Chem 359 1978 1757 1770
4. A. Henschen, F. Lottspeich, M. Kehl, and C. Southan Covalent structure of fibrinogen Ann NY Acad Sci 408 1983 28 43
5. P.D. Hoeprich, and R.F. Doolittle Dimeric half-molecules of human fibrinogen are joined through disulphide bonds in an antiparallel orientation Biochemistry 22 1983 2049 2055
6. M.W. Marino, G.M. Fuller, and F.F. Elder Chromosomal localization of human and rat. A alpha, B beta, and gamma fibrinogen genes by in situ hybridization Cytogenet Cell Gene 422 1986 36
7. B. Blombäck, B. Hessel, D. Hogg, and L. Therkildsen A two-step fibrinogen-fibrin transition in blood coagulation Nature 275 1978 501 505
8. C.G. Binnie, and S.T. Lord The fibrinogen sequences that interact with thrombin Blood 81 1993 3186 3192
9. G.F. Smith, and N.U. Bang Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer Biochemistry 11 1972 2958 2966
10. B. Blombäck Fibrinogen and fibrin - proteins with complex roles in haemostasis and thrombosis Thromb Res 83 1996 1 75
11. R.F. Doolittle, K.G. Cassman, R. Chen, J.J. Sharp, and G.L. Wooding Correlation of the mode of fibrin polymerisation with the pattern of cross-linking Ann NY Acad Sci 202 1972 114 126
12. P.A. McKee, M.L. Schwarz, S.V. Pizzo, and R.L. Hill Cross-linking of fibrin by fibrin-stabilizing factor Ann NY Acad Sci 202 1972 127 148
13. H. Kanaide, and J.R. Shainoff Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa) J Lab Clin Med 85 1975 574 597
14. E.F. Mammen Fibrinogen abnormalities Semin Thromb Hemost 9 1983 1 9
15. C.V. Dang, W.R. Bell, and M. Shuman The normal and morbid biology of fibrinogen Am J Med 87 1989 567 576
16. E.A. Beck Congenital abnormalities of fibrinogen Clin Haematol 8 1979 169 181
17. J. McDonagh, and N. Carrell Disorders of fibrinogen structure and function R.W. Colman J. Hirsh V.J. Marder E.W. Salzman Hemostasis and thrombosis. Basic principles arid clinical practice 2nd ed. 1987 J.B. Lippincott Company Philadelphia, PA 301 317
18. H. al-Mondhiry, and W.C. Ehmann Congenital afibrinogenaemia Am J Hematol 46 1994 343 347
19. M. Lak, M. Keihani, F. Elahi, F. Peyvandi, and P.M. Mannucci Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia Br J Haematol 107 1999 204 206
20. J. Martinez Congenital dysfibrinogenemia Curr Opin Hematol 4 1997 357 365
21. M. Neerman-Arbez Fibrinogen gene mutations accounting for congenital afibrinogenaemia Ann NY Acad Sci 936 2001 496 508
22. S. Duga, R. Asselta, E. Santagostino, S. Zeinali, T. Simonic, and M. Malcovati Missense mutations in the human β fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion Blood 95 2000 1336 1341
23. D.K. Galanakis Dysfibrinogenemia. A current perspective Clin Lab Med 4 1984 395 418
24. S.O. Brennan, A.P. Fellowes, and P.M. George Molecular mechanisms of hypo- and afibrinogenemia Ann NY Acad Sci 936 2001 91 100
25. W. Kreuz, E. Meili, K. Peter-Salonen, A. Dobrkovska, J. Devay, and S. Haertel Pharmacokinetic properties of a pasteurised fibrinogen concentrate Transfus Apher Sci 32 3 2005 239 246
26. G. Müller-Berghaus, and I. Mahn Fibrinogenumsatz unter physiologischen und pathologischen bedingungen [Fibrinogen turnover under physiological and 'pathological conditions] K. Schimpf Fibrinogen, Fibrin und Fibrinkleber [fibrinogen, fibrin and fibrin glue] 1980 Schattauer Verlag Stuttgart, New York 69 83
27. J.M.L. Henselmans, K. Miejer, R. Haaxma, J. Hew, and J. van der Meer Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient. Diagnostic pitfalls and therapeutic options Stroke 30 1999 2479 2482
28. W. Korte, and A. Feldges Increased prothrombin activation in a patient with congenital afibrinogenaemia is reversible by fibrinogen substitution Clin Invest 72 1994 396 398
29. A.J. Reininger, C.B. Reininger, M. Spannagl, A. Mellinghoff, A. Porr, and U. Heinzmann Effect of fibrinogen substitution in afibrinogenaemia on hemorheology and platelet function Thromb Haemost 74 1995 853 858